<code id='81CA2CE4C1'></code><style id='81CA2CE4C1'></style>
    • <acronym id='81CA2CE4C1'></acronym>
      <center id='81CA2CE4C1'><center id='81CA2CE4C1'><tfoot id='81CA2CE4C1'></tfoot></center><abbr id='81CA2CE4C1'><dir id='81CA2CE4C1'><tfoot id='81CA2CE4C1'></tfoot><noframes id='81CA2CE4C1'>

    • <optgroup id='81CA2CE4C1'><strike id='81CA2CE4C1'><sup id='81CA2CE4C1'></sup></strike><code id='81CA2CE4C1'></code></optgroup>
        1. <b id='81CA2CE4C1'><label id='81CA2CE4C1'><select id='81CA2CE4C1'><dt id='81CA2CE4C1'><span id='81CA2CE4C1'></span></dt></select></label></b><u id='81CA2CE4C1'></u>
          <i id='81CA2CE4C1'><strike id='81CA2CE4C1'><tt id='81CA2CE4C1'><pre id='81CA2CE4C1'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:35
          Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed. Joe Raedle/Getty Images

          Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed, per reports from Bloomberg.

          Experts largely hailed the rumored sale as a good buy, citing the management of chronic conditions in the Medicare Advantage population through primary care, ChenMed’s specialty, as an area with huge innovation and cost savings over the last 10 years.

          advertisement

          “If you’re going to purchase primary care in the senior space, there’s no one better than ChenMed. The only other one that might be better or equivalent would be Oak Street, but they were just purchased,” said Jon Kaplan, a senior partner at BCG. “In the world of great primary care practices to buy, in my top two are Oak Street and ChenMed, and one of them’s available, one’s not.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Medicare drug price negotiation’s day in court
          Medicare drug price negotiation’s day in court

          AdobeYou’rereadingthewebeditionofD.C.Diagnosis,STAT’stwice-weeklynewsletteraboutthepoliticsandpolicy

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          The Biogen Aduhelm mess could happen again

          BiogenrecentlyannounceditwillceaseboththestudyandsaleofitsAlzheimer'sdrugAduhelm.JessicaRinaldi/TheB